32 results
8-K
EX-99.3
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
referrals, improperly reported government pricing metrics such as Best Price or Average Manufacturer Price, improper use of Medicare provider or supplier
8-K
EX-99.4
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
to try new therapies and of physicians to prescribe these therapies;
the extent and strength of Elicio’s third-party manufacturer and supplier support
8-K
EX-99.5
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
estimate the timing of if and when they will occur. We could also enter into additional research, manufacturing, supplier and other agreements in the future
424B3
zkjn23nj3aq
28 Apr 23
Prospectus supplement
4:07pm
S-4/A
EX-10.29
gqf594
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.34
3dmnlkeyts7zy
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
nfviam
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
424B5
wen 9vai2vs
24 May 22
Prospectus supplement for primary offering
4:02pm
424B3
fck91
24 May 22
Prospectus supplement
4:01pm
S-3
x0g gc3i8
16 May 22
Shelf registration
5:23pm